You are here

Dielectrophoretic Microfluidic Protein Analysis System

Award Information
Agency: Department of Defense
Branch: Office for Chemical and Biological Defense
Contract: W911NF-10-C-0063
Agency Tracking Number: C091-104-0013
Amount: $749,986.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: CBD09-104
Solicitation Number: 2009.1
Solicitation Year: 2009
Award Year: 2010
Award Start Date (Proposal Award Date): 2010-03-26
Award End Date (Contract End Date): 2012-03-26
Small Business Information
Photonic Systems Division, 20600 Gramercy Place, Bldg. 100, Torrance, CA, 90501
DUNS: 153865951
HUBZone Owned: N
Woman Owned: Y
Socially and Economically Disadvantaged: N
Principal Investigator
 Gregory Zeltser
 Principal Scientist
 (310) 320-3088
Business Contact
 Gordon Drew
Title: Chief Financial Officer
Phone: (310) 320-3088
Research Institution
To address the U.S. Army CBD need for a low-cost, universal, robust, and fieldable device for rapid, reproducible identification of protein variants from biological samples with high throughput, Physical Optics Corporation (POC) proposes to develop a new Dielectrophoretic Microfluidic Protein Analysis (DiMiPA) system based on an electrodeless dielectrophoresis-based, continuous-flow protein separation technique followed by protein variants quantification and identification via detection of the separated protein bands by UV absorption spectrometry and enhanced Raman spectrometry with POC-designed SERS substrates. The DiMiPA system will be composed of a microfluidic chip, an AC power supply, a syringe pump, and a readout unit. The DiMiPA tool will rapidly (10 min) and with high resolution and reproducibility separate protein variants, preparing them for identification by the readout unit. The DiMiPA system will be an inexpensive, portable, and easy-to-use automated instrument. In Phase I, POC demonstrated the feasibility of the DiMiPA device by fabricating a prototype and demonstrating its capability to separate allozymes of sulfotransferase (SULT1A1), SULT1A1*1, and SULT1A1*3, which differ from each other by a single amino acid. In Phase II, DiMiPA will be optimized to enhance system throughput and identification resolution to identify allozymes of SULT1A1 and heat shock protein 70, HSP70-1A, and HSP70-1B.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government